References
- Blood v.95 Chemokine receptors and their role in inflammation and inflectious diseases Murdoch,C.;A.Finn
- Blood v.90 Chemokines Rollins,B.J.
- Immunity v.14 Chemokines, chemokine receptors, and allograft rejection Nelson,P.J.;A.M.Krensky https://doi.org/10.1016/S1074-7613(01)00118-2
- Nature v.392 Chemokines and leukocyte traffic Baggiolini,M. https://doi.org/10.1038/33340
- New Engl. J. Med. v.338 Chemokines: Chemotaotic cytokines that mediate inflammation Baggiolini,A.D. https://doi.org/10.1056/NEJM199802123380706
- Immunol. Rev. v.177 Chemokines, chemokine receotirs and hematopoiesis Youn,B.S.;C.Mantel'H.E.Broxmeyer https://doi.org/10.1034/j.1600-065X.2000.17701.x
- Curr. Opin. Rheumatol v.13 Chemokines and angiogenesis Szskanecz,Z.;A.E.Koch https://doi.org/10.1097/00002281-200105000-00009
- Nat. Immunol v.2 Chemokines and disease Gerard,C.;B.J.Rollins https://doi.org/10.1038/84209
- J. Exp. Med. v.192 Natural protelytic processing of hemofiltrate CC chemokine 1 generates a potent CC chemokine receptor (CCR)1 and CCR5 agonist with anti-HIV properties Detheux,M.;L.Standker;J.Vakili;J.Munch;U.Forssmann;K.Adermann;S.Pohlmann;G.Vassart;F.Kirhhoff;M.Parmentier;W.G.Forssmann https://doi.org/10.1084/jem.192.10.1501
- J. Immunol v.159 Molecular cloning of leukotactin-1: A novel human beta-chemokine, a chemoattractant for neutrophils, monocytes, and lymphocytes, and a potent agonist at CC chemokine receotors 1 and 3 Youn,B.S.;S.M.Zhang;E.K.Lee;D.H.Park;H.E.Broxmeyer;P.M.Murphy;M.Locati;J.E.Peast;K.K.Kim;K.Antol;B.S.Kwon
- J. Immunol v.162 Differential effects of leukotactin-1 and mactophage inflammatoru protein-1 alpha on neutrophils mediated by CCR1 Zhang,S.;B.S.Youn;J.L.Gao;P.M.Murphy;B.S.Kwon
- Exp. Hematol. v.27 Protective effects of BB-10010 treatment on chemotherapy-induced neutropenia in mice Gilmore,G.L.;D.K.DePasquale;R.K.Shadduck https://doi.org/10.1016/S0301-472X(98)00052-6
- Nature v.344 Idenrification and characterization of an inhibitor of haemopoietic stem cell proliferation Graham,G.J.;E.G.Wright;R.Hewick;S.D.Wolpe;N.M.Wilkie;D.Donaldson;S.Lorimore;I.B.Pragnell https://doi.org/10.1038/344442a0
- Growth Factors v.12 MIP-1 alpha increases the self-renewal capacity of the hemopoietic spleen-colony-forming cells following hydroxyurea treatment in vivo Lord,B.I. https://doi.org/10.3109/08977199509028960
- Proc. Natl. Acad. Sci. v.90 Unresponsiveness of promitive chronic myeloid leukemia cells to macropage inflammatory protein 1 alpha, an inhibitor of promitive normal hematopoietic cells Eaves,C.J.;J.D.Cashman;S.D.Wolpe;A.C.Eaves https://doi.org/10.1073/pnas.90.24.12015
- Cancer Biology (2nd ed.) King,R.J.B.
- J. Hematother. Stem Cell Res. v.12 Effect of leukotactin-1 on the protection in vivo of myeloid progenitor cells against cytoxic chemotherapeutics Kim,W.Y.;H.E.Broxmeyer;I.S.Han;D.H.Park;K.M.Lee;D.S.Vinayl;B.S.Kwon https://doi.org/10.1089/152581603321210181
- Stem Cells v.19 Chemokine regulation of notmal and pathologic immune responses Christopherson,K.;R.Hromas https://doi.org/10.1634/stemcells.19-5-388
- Br. J. Cancer v.75 Continuous infusion of mactophage inflammatory protein MIP-1 alpha enhances leucocyte recovery and haemopoietic progenitor cell mobilization after cyclophosphamide Marshall,E.;L.B.Woolford;B.I.Lord https://doi.org/10.1038/bjc.1997.294
- Atherosclerosis v.161 A nevel chemokine, leukoractin-1, induces chemotaxis, proatherogenic cytokines, and tissue factor expression in atheroslerosis Lee,W.H.;S.H.Kim;E.M.Jeong;Y.H.Choi;D.I.Kim;B.B.Lee;Y.S.Cho;B.S.Kwon.J.E.Park https://doi.org/10.1016/S0021-9150(01)00634-7